title: The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
abstract: Cotransfection of primary rat embryo fibroblasts (REF) with c-Jun and activated Ras leads to oncogenic transformation and this process requires the phosphorylation of the N-terminal domain of c-Jun. Ras augments this phosphorylation and, consequently activates the c-Jun transactivation property of TRE (TPA Responsive Element)-dependent promoters. To analyse the role of the c-Jun C-terminal phosphorylation site in oncogenic cooperation we tested the activities of N-terminal c-Jun Ala(63/73) (named Nt), C-terminal c-Jun Ala(234/242/246/252) (named Ct) and (Nt+Ct)-with both mutations-non-phosphorylatable c-Jun mutants. In cooperation with Ras, the Ct mutant and wt c-Jun display similar oncogenic properties whereas the Nt form was defective in transforming REF cells. Unexpectedly, the Nt+Ct mutant exhibited identical oncogenic properties to wt c-Jun, demonstrating that the Ct mutation rescues in cis the Nt mutation. The transcriptional activity and the capacity to bind the c-Jun coactivator CREB Binding Protein (CBP) were enhanced by Ras for the wt and Ct proteins but not for the Nt mutant. Interestingly, the Nt+Ct mutant presents identical transactivation and CBP binding activities to wt c-Jun. Therefore the rescue in cis of the defective Nt mutation by the Ct mutation seems to be due to the recovery of CBP binding. Our results revealed that the process of oncogenic cooperation can occur between Ras and the Nt+Ct non-phosphorylatable c-Jun protein.
authors.affiliation: INSERM E99-11, Faculté de Médecine, Université de Nice Sophia-Antipolis, Av. de Valombrose, 06107 Nice, France.
authors.forename: F
authors.initials: F
authors.lastname: Bost
authors.forename: L
authors.initials: L
authors.lastname: Caron
authors.forename: E
authors.initials: E
authors.lastname: Vial
authors.forename: N
authors.initials: N
authors.lastname: Montreau
authors.forename: I
authors.initials: I
authors.lastname: Marchetti
authors.forename: V
authors.initials: V
authors.lastname: Dejong
authors.forename: L
authors.initials: L
authors.lastname: Defize
authors.forename: M
authors.initials: M
authors.lastname: Castellazzi
authors.forename: B
authors.initials: B
authors.lastname: Binétruy
mesh_terms: D000409:Alanine / Q000737:chemistry; D000818:Animals; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D005347:Fibroblasts / Q000473:pathology; D017930:Genes, Reporter; D016758:Genes, jun; D011905:Genes, ras; D005816:Genetic Complementation Test; D051379:Mice; D016297:Mutagenesis, Site-Directed; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D016755:Proto-Oncogene Proteins c-jun / Q000737:chemistry / Q000502:physiology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000502:physiology; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000502:physiology; D013329:Structure-Activity Relationship; D014162:Transfection; D014410:Tumor Stem Cell Assay
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D016755:Proto-Oncogene Proteins c-jun; D011993:Recombinant Fusion Proteins; D004247:DNA; D016283:Proto-Oncogene Proteins p21(ras); D000409:Alanine